HRP20080452T3 - Orally disintegrating pharmaceutical composition comprising risperidone - Google Patents
Orally disintegrating pharmaceutical composition comprising risperidoneInfo
- Publication number
- HRP20080452T3 HRP20080452T3 HR20080452T HRP20080452T HRP20080452T3 HR P20080452 T3 HRP20080452 T3 HR P20080452T3 HR 20080452 T HR20080452 T HR 20080452T HR P20080452 T HRP20080452 T HR P20080452T HR P20080452 T3 HRP20080452 T3 HR P20080452T3
- Authority
- HR
- Croatia
- Prior art keywords
- risperidone
- pharmaceutical composition
- orally disintegrating
- disintegrating pharmaceutical
- orally
- Prior art date
Links
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 2
- RAPZEAPATHNIPO-UHFFFAOYSA-N risperidone Chemical compound FC1=CC=C2C(C3CCN(CC3)CCC=3C(=O)N4CCCCC4=NC=3C)=NOC2=C1 RAPZEAPATHNIPO-UHFFFAOYSA-N 0.000 title abstract 2
- 229960001534 risperidone Drugs 0.000 title abstract 2
- 238000005469 granulation Methods 0.000 abstract 1
- 230000003179 granulation Effects 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 229920000193 polymethacrylate Polymers 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Psychiatry (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurosurgery (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE102004028940A DE102004028940A1 (de) | 2004-06-15 | 2004-06-15 | Oral zerfallende pharmazeutische Zusammensetzung, die Risperidon enthält |
PCT/EP2005/006375 WO2005123084A1 (en) | 2004-06-15 | 2005-06-14 | Orally disintegrating pharmaceutical composition comprising risperidone |
Publications (1)
Publication Number | Publication Date |
---|---|
HRP20080452T3 true HRP20080452T3 (en) | 2008-10-31 |
Family
ID=34971693
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HR20080452T HRP20080452T3 (en) | 2004-06-15 | 2008-09-17 | Orally disintegrating pharmaceutical composition comprising risperidone |
Country Status (13)
Country | Link |
---|---|
EP (1) | EP1768673B1 (pl) |
AT (1) | ATE402706T1 (pl) |
DE (2) | DE102004028940A1 (pl) |
EA (1) | EA010178B1 (pl) |
ES (1) | ES2311230T3 (pl) |
HR (1) | HRP20080452T3 (pl) |
NO (1) | NO20070187L (pl) |
PL (1) | PL1768673T3 (pl) |
PT (1) | PT1768673E (pl) |
RS (1) | RS50609B (pl) |
SI (1) | SI1768673T1 (pl) |
UA (1) | UA87692C2 (pl) |
WO (1) | WO2005123084A1 (pl) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20080085310A1 (en) * | 2006-10-06 | 2008-04-10 | Maria Oksana Bachynsky | Capecitabine rapidly disintegrating tablets |
TW200835527A (en) * | 2006-12-26 | 2008-09-01 | Shionogi & Co | Orally disintegrating tablet and bitter taste-masked formulation comprising risperidone |
CN101269014B (zh) * | 2007-03-21 | 2012-11-14 | 江苏万特制药有限公司 | 一种利培酮的口腔崩解片及其制备方法 |
WO2008152729A1 (ja) * | 2007-06-15 | 2008-12-18 | Teikokumedix Co., Ltd. | リスペリドンを含むゼリー状の医薬組成物 |
CN101485636B (zh) * | 2008-01-14 | 2010-12-22 | 齐鲁制药有限公司 | 利培酮口腔崩解片及其制备方法 |
WO2013095314A1 (en) * | 2011-12-19 | 2013-06-27 | Mahmut Bilgic | Pharmaceutical formulations comprising risperidone |
WO2013100876A1 (en) * | 2011-12-27 | 2013-07-04 | Mahmut Bilgic | Risperidone formulations |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0910345B1 (en) * | 1996-06-17 | 2002-02-13 | Janssen Pharmaceutica N.V. | Biconvex rapidly disintegrating dosage forms |
US7919119B2 (en) * | 1999-05-27 | 2011-04-05 | Acusphere, Inc. | Porous drug matrices and methods of manufacture thereof |
US6395300B1 (en) * | 1999-05-27 | 2002-05-28 | Acusphere, Inc. | Porous drug matrices and methods of manufacture thereof |
MXPA03000985A (es) * | 2001-07-27 | 2004-04-02 | Yamanouchi Pharma Co Ltd | Composicion que comprende particulas finas de liberacion sostenida para tabletas de desintegracion rapida en la cavidad bucal y metodo de fabricacion de la misma. |
US20040265375A1 (en) * | 2003-04-16 | 2004-12-30 | Platteeuw Johannes J. | Orally disintegrating tablets |
AU2004238321B2 (en) * | 2003-05-07 | 2009-08-27 | Samyang Biopharmaceuticals Corporation | Highly plastic granules for making fast melting tablets |
WO2005120463A1 (en) * | 2004-06-09 | 2005-12-22 | Ranbaxy Laboratories Limited | Rapidly disintegrating tablets of risperidone |
-
2004
- 2004-06-15 DE DE102004028940A patent/DE102004028940A1/de not_active Withdrawn
-
2005
- 2005-06-14 UA UAA200700399A patent/UA87692C2/ru unknown
- 2005-06-14 RS RSP-2008/0419A patent/RS50609B/sr unknown
- 2005-06-14 AT AT05757277T patent/ATE402706T1/de not_active IP Right Cessation
- 2005-06-14 PT PT05757277T patent/PT1768673E/pt unknown
- 2005-06-14 EA EA200700023A patent/EA010178B1/ru not_active IP Right Cessation
- 2005-06-14 SI SI200530422T patent/SI1768673T1/sl unknown
- 2005-06-14 ES ES05757277T patent/ES2311230T3/es active Active
- 2005-06-14 DE DE602005008607T patent/DE602005008607D1/de active Active
- 2005-06-14 EP EP05757277A patent/EP1768673B1/en active Active
- 2005-06-14 PL PL05757277T patent/PL1768673T3/pl unknown
- 2005-06-14 WO PCT/EP2005/006375 patent/WO2005123084A1/en active Application Filing
-
2007
- 2007-01-11 NO NO20070187A patent/NO20070187L/no not_active Application Discontinuation
-
2008
- 2008-09-17 HR HR20080452T patent/HRP20080452T3/xx unknown
Also Published As
Publication number | Publication date |
---|---|
RS50609B (sr) | 2010-06-30 |
DE602005008607D1 (de) | 2008-09-11 |
UA87692C2 (ru) | 2009-08-10 |
EP1768673A1 (en) | 2007-04-04 |
ATE402706T1 (de) | 2008-08-15 |
EP1768673B1 (en) | 2008-07-30 |
DE102004028940A1 (de) | 2006-01-12 |
PL1768673T3 (pl) | 2009-01-30 |
NO20070187L (no) | 2007-03-02 |
PT1768673E (pt) | 2008-10-21 |
EA010178B1 (ru) | 2008-06-30 |
SI1768673T1 (sl) | 2008-12-31 |
EA200700023A1 (ru) | 2007-06-29 |
ES2311230T3 (es) | 2009-02-01 |
WO2005123084A1 (en) | 2005-12-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX2009001294A (es) | Granulo y tableta que se desintegra por vía oral que comprende oxicodona. | |
TW200744602A (en) | Administration of dipeptidyl peptidase inhibitors | |
HRP20080452T3 (en) | Orally disintegrating pharmaceutical composition comprising risperidone | |
MX2009002772A (es) | Uso de 2-6-(3-amino-piperidin-1-il)-3-metil-2,4-dioxo-3,4-dihidro- 2h-pirimidin-1-ilmetil-4-fluoro-benzonitrilo. | |
AP2007003973A0 (en) | Novel dideptidyl peptidase IV inhibitors, pharmaceutical compositions containing them, and proces for their preparation | |
MY157661A (en) | Bendamustine pharmaceutical compositions | |
UA90875C2 (ru) | Лекарственные формы пролонгированного действия, которые содержат ранолазин | |
SG153800A1 (en) | Pharmaceutical compositions | |
MX2008001799A (es) | Composicion farmaceutica que comprende un inhibidor de dipeptidil peptidasa iv. | |
GEP20094679B (en) | Dipeptidyl peptidase inhibitors | |
TNSN08178A1 (en) | Triazolopyridine derivatives as inhibitors of lipases and phospholipases | |
ZA200806778B (en) | N-Hydroxyacrylamide compounds | |
MX343358B (es) | Tabletas de acetato de ulipristal. | |
MX2007001953A (es) | Enantiomeros de pirimidonas fusionadas seleccionadas y usos en el tratamiento y prevencion del cancer. | |
GEP20125458B (en) | Matrix metalloproteinase inhibitors | |
PL382842A1 (pl) | Sole donepezilu odpowiednie do otrzymywania kompozycji farmaceutycznych | |
UA94036C2 (ru) | Фармацевтическая композиция бендамустина, предназначенная для лиофилизации | |
TW200738649A (en) | Calcilytic compounds | |
ZA200604874B (en) | Pharmaceutical compositions | |
TW200730190A (en) | New combination to treat liver fibrosis | |
MY149864A (en) | Flavouring-containing pharmaceutical formulations with improved pharmaceutical properties | |
MX2009003755A (es) | Cristal novedoso de (s)-(+)-2-(2-clorofenil)-2-hidroxietil carbamato. | |
WO2006005578A3 (en) | Solid pharmaceutical composition comprising mirtazapine | |
MX2009005804A (es) | Composicion farmaceutica de memantina. | |
IL191992A0 (en) | Inhibitors of cysteine proteases, the pharmaceutical compositions thereof and their therapeutic applications |